MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

214.35 -0.67 (-0.31%)
Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,649,785
Open 215.61
Bid (Size) 214.50 (100)
Ask (Size) 214.70 (100)
Prev. Close 215.02
Today's Range 213.88 - 217.34
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 3.06%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗
Income investors can rely on these stocks. 
Via The Motley Fool
Topics Intellectual Property
News headline image
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie ↗
These stocks sport dividend yields ranging from 2.9% to 5.5%. 
Via The Motley Fool

Performance

YTD
-6.5%
-6.5%
1 Month
-5.5%
-5.5%
3 Month
-7.6%
-7.6%
6 Month
+16.0%
+16.0%
1 Year
+24.2%
+24.2%

More News

Read More
News headline image
Could Buying This Stock Today Pay Off Big Over the Next 5 Years? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Call Options Spike 2,599%: Tracking the Big Bet ↗
Via MarketBeat
AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly ↗
Via Stocktwits
News headline image
Genmab Reports Mixed Results From Late-Stage Trial Of Lymphoma Drug ↗
Via Stocktwits
News headline image
3 Absurdly Cheap Growth Stocks to Buy in 2026 ↗
Via The Motley Fool
News headline image
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Earnings
News headline image
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI, JPMorgan Earnings: Why MSFT, NVDA, ABBV, ABAT Are Also On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence Credit Cards ETFs
News headline image
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B ↗
Via Stocktwits
News headline image
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
3 No-Brainer Dividend Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
This ETF Is Proof That the Healthcare Rebound Is Real ↗
Via MarketBeat
Topics ETFs
News headline image
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
Via MarketMinute
News headline image
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio ↗
Via The Motley Fool
Topics Economy Intellectual Property Lawsuit
News headline image
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
Via MarketMinute
Topics Intellectual Property
News headline image
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
Via MarketMinute
Topics Intellectual Property
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 We Question
Via StockStory
News headline image
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating ↗
Via MarketBeat
News headline image
Revolution Medicines Stock Soars On Report Of AbbVie Takeover ↗
Via Stocktwits
News headline image
Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
3 Healthcare Stocks with Exciting Potential
Via StockStory
Topics Stocks
Top S&P500 movers in Monday's session ↗
Via Chartmill
News headline image
Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗
Via MarketBeat
Topics Artificial Intelligence Death
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 214.35
When was AbbVie last traded?
The last trade of AbbVie was at 01/16/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story